New research shows that the final stage of the normal inflammatory process may be disrupted in patients with Alzheimer's disease. A study shows that levels in the brain and cerebrospinal fluid of the molecules necessary for tissue recovery through the clearance of harmful inflammatory substances are lower than normal in patients with Alzheimer's disease. The study also showed association between the lower levels of these molecules with impaired memory function.